BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36007589)

  • 1. Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study.
    Tcheugui JB; Zhang S; McEvoy JW; Ndumele CE; Hoogeveen RC; Coresh J; Selvin E
    Am J Med; 2022 Dec; 135(12):1461-1467. PubMed ID: 36007589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.
    Jia X; Al Rifai M; Hoogeveen R; Echouffo-Tcheugui JB; Shah AM; Ndumele CE; Virani SS; Bozkurt B; Selvin E; Ballantyne CM; Nambi V
    JAMA Cardiol; 2023 Mar; 8(3):222-230. PubMed ID: 36753229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
    Hussain A; Sun W; Deswal A; de Lemos JA; McEvoy JW; Hoogeveen RC; Matsushita K; Aguilar D; Bozkurt B; Virani SS; Shah AM; Selvin E; Ndumule C; Ballantyne CM; Nambi V
    J Am Coll Cardiol; 2021 Feb; 77(5):559-571. PubMed ID: 33538254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
    Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
    Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
    J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP and All-Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study.
    Echouffo-Tcheugui JB; Zhang S; Daya N; McEvoy JW; Tang O; Juraschek SP; Ndumele CE; Coresh J; Christenson RH; Selvin E
    J Am Heart Assoc; 2023 Jun; 12(11):e029110. PubMed ID: 37232235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
    Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
    BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
    deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
    J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
    Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
    JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.
    van Peet PG; de Craen AJ; Gussekloo J; de Ruijter W
    Age (Dordr); 2014 Jun; 36(3):9660. PubMed ID: 24807464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events - The Japan Morning Surge-Home Blood Pressure Study.
    Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
    Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
    Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
    Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.